Matthew Weinberg Writes for Tobacco Reporter

June 17, 2014

CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations.

TAGS:

August 16, 2013

Matthew Weinberg Writes for International Clinical Trials (ICT) Magazine

In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent...

February 11, 2014

Drug Companies Face Stricter Clinical Trial Regulation Worldwide

For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at jeff.antos@weinberggroup.com or 202.280.0815.

March 10, 2019

ProPharma Group Announces Acquisition of Southwood Research

ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Southwood Research. Based in Buckinghamshire, United Kingdom, Southwood Research is a leading provider of...